Correlation Between Johnson Johnson and OncoCyte Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and OncoCyte Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and OncoCyte Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and OncoCyte Corp, you can compare the effects of market volatilities on Johnson Johnson and OncoCyte Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of OncoCyte Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and OncoCyte Corp.

Diversification Opportunities for Johnson Johnson and OncoCyte Corp

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Johnson and OncoCyte is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and OncoCyte Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoCyte Corp and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with OncoCyte Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoCyte Corp has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and OncoCyte Corp go up and down completely randomly.

Pair Corralation between Johnson Johnson and OncoCyte Corp

Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.29 times more return on investment than OncoCyte Corp. However, Johnson Johnson is 3.42 times less risky than OncoCyte Corp. It trades about 0.06 of its potential returns per unit of risk. OncoCyte Corp is currently generating about -0.01 per unit of risk. If you would invest  14,546  in Johnson Johnson on September 1, 2024 and sell it today you would earn a total of  955.00  from holding Johnson Johnson or generate 6.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  OncoCyte Corp

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain steady and the new chaos on Wall Street may also be a sign of medium-term gains for the company stakeholders.
OncoCyte Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Johnson Johnson and OncoCyte Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and OncoCyte Corp

The main advantage of trading using opposite Johnson Johnson and OncoCyte Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, OncoCyte Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoCyte Corp will offset losses from the drop in OncoCyte Corp's long position.
The idea behind Johnson Johnson and OncoCyte Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stocks Directory
Find actively traded stocks across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories